Design of a magnetic nanocarrier containing phyllacanthone as delivery of anticancer phytochemical: Characterization and theranostic in vitro applications
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Phytochemistry and Biological Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cancer nanomedicine: a review of recent success in drug delivery10.1186/s40169-017-0175-0 ↗
2. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. Cancer chemotherapy resistance: mechanisms and recent breakthrough in targeted drug delivery10.1016/j.ejphar.2023.176013 ↗
4. Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway10.3389/fphar.2021.639628 ↗
5. Natural products as anticancer agents: current status and future perspectives10.3390/molecules27238367 ↗
6. How chemotherapy and radiotherapy damage the tissue: comparative biology lessons from feather and hair models10.1111/exd.13846 ↗
7. Natural products as sources of new drugs over the rearly four decades from 01/1981 to 09/201910.1021/acs.jnatprod.9b01285 ↗
8. Screening of bioactivities and toxicity of Cnidoscolus quercifolius Pohl10.1155/2016/7930563 ↗
9. Prospecção fitoquímica e avaliação do potencial antioxidante de Cnidoscolus phyllacanthus (müll. Arg.) Pax & k.hoffm. Oriundo de apodi – RN10.1590/1983-084X/15_058 ↗
10. Chemical constituents and cytotoxic activity of Cnidoscolus phyllacanthus10.5935/1984-6835.20160015 ↗
11. Bis-nor-diterpene from Cnidoscolus quercifolius (Euphorbiaceae) induces tubulin depolymerization-mediated apoptosis in BRAF-mutated melanoma cells10.1016/j.cbi.2022.109849 ↗
12. Cyclodextrins and inorganic nanoparticles: another tale of synergy10.1016/j.cis.2020.102338 ↗
13. Cyclodextrin inclusion complexes for improved drug bioavailability and activity: synthetic and analytical aspects10.3390/pharmaceutics15092345 ↗
14. Cyclodextrin-based nanoparticles for pharmaceutical applications: a review10.1007/s10311-021-01275-y ↗
15. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications10.1016/j.addr.2019.01.005 ↗
16. High biocompatibility, MRI enhancement, and dual chemo- and thermal-therapy of curcumin-encapsulated alginate/Fe3O4 nanoparticles10.3390/pharmaceutics15051523 ↗
17. Multifunctional nanocarriers of Fe3O4@PLA-PEG/curcumin for MRI, magnetic hyperthermia and drug delivery10.2217/nnm-2022-0070 ↗
18. Recent progress of magnetic nanoparticles in biomedical applications: a review10.1002/nano.202000162 ↗
19. Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine10.7150/ntno.86467 ↗
20. Spectroscopic and photoacoustic characterization of encapsulated iron oxide super-paramagnetic nanoparticles as a new multiplatform contrast agent10.1016/j.saa.2018.03.025 ↗
21. Iron oxide nanoparticles as multimodal imaging tools10.1039/C9RA08612A ↗
22. Clinical magnetic hyperthermia requires integrated magnetic particle imaging
23. In vivo magnetic nanoparticle hyperthermia: a review on preclinical studies, low-field nano-heaters, noninvasive thermometry and computer simulations for treatment planning10.1080/02656736.2020.1800831 ↗
24. Targeted delivery and pH-responsive release of stereoisomeric anti-cancer drugs using β-cyclodextrin assemblied Fe3O4 nanoparticles10.1016/j.apsusc.2015.09.189 ↗
25. Magnetic targeted nanoparticles based on β-cyclodextrin and chitosan for hydrophobic drug delivery and a study of their mechanism10.1039/C7RA02398G ↗
26. Nanotechnology-based combinational drug delivery systems for breast cancer treatment10.1080/00914037.2018.1517348 ↗
27. Molecular encapsulator–appended poly(vinyl alcohol) shroud on ferrite nanoparticles. Augmented cancer–drug loading and anticancer property10.1016/j.msec.2018.07.058 ↗
28. Designed poly(ethylene glycol) conjugate-erbium-doped magnetic nanoparticle hybrid carrier: enhanced activity of anticancer drug10.1007/s10853-020-05466-w ↗
29. Combining magnetic hyperthermia and dual T1/T2 MR imaging using highly versatile iron oxide nanoparticles10.1039/C8DT04685A ↗
30. β-Cyclodextrin based magnetic nanoconjugates for targeted drug delivery in cancer therapy10.1039/C6RA18030B ↗
31. Magnetic nanoparticles grafted with β-cyclodextrin–polyurethane polymer as a novel nanomagnetic polymer brush catalyst for nucleophilic substitution reactions of benzyl halides in water10.1016/j.molcata.2012.08.012 ↗
32. Preparation of thermally stable magnetic poly(urethane-imide)/nanocomposite containing β-cyclodextrin cavities as new adsorbent for lead and cadmium10.1007/s10965-020-02255-6 ↗
33. β-cyclodextrin based dual-responsive multifunctional nanotheranostics for cancer cell targeting and dual drug delivery10.1016/j.carbpol.2018.11.049 ↗
34. Anti-melanoma potential of inclusion complexes containing phyllacanthone in β-cyclodextrin and sulfobutyl-ether-β-cyclodextrin
35. Plasmonically enhanced two-photon absorption induced photoacoustic microscopy with laser-synthesized TiN nanoparticles10.1063/5.0101658 ↗
36. Characterization and chemical stability of hydrophilic and hydrophobic magnetic nanoparticles10.1590/1980-5373-mr-2016-0707 ↗
37. Microwave assisted synthesis of oleic acid modified magnetite nanoparticles for benzene adsorption
38. Influence of β-cyclodextrin on morphologies and chemical, thermal, and mechanical properties of non-chain extended polyurethane elastomers10.1007/s10965-016-1046-x ↗
39. AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticles10.1039/C7NJ02860A ↗
40. Preparation of Aun quantum clusters with catalytic activity in β-cyclodextrin polyurethane nanosponges10.1016/j.carbpol.2015.09.010 ↗
41. Carvacrol/β-cyclodextrin inclusion complex inhibits cell proliferation and migration of prostate cancer cells10.1016/j.fct.2019.01.003 ↗
42. Alpha- and beta-cyclodextrin inclusion complexes with 5-Fluorouracil: characterization and cytotoxic activity evaluation10.3390/molecules21121644 ↗
43. Superparamagnetic Fe3O4 nanoparticles, synthesis and surface modification10.1016/j.mssp.2015.05.035 ↗
44. Water dispersible oleic acid-coated Fe3O4 nanoparticles for biomedical applications10.1016/j.jmmm.2014.10.137 ↗
45. Ternary cyclodextrin polyurethanes containing phosphate groups: synthesis and complexation of ciprofloxacin10.1016/j.carbpol.2016.05.101 ↗
46. Synthesis of magnetic silver cyclodextrin nanocomposite as catalyst for reduction of nitro aromatics and organic dyes10.1016/j.molliq.2019.112279 ↗
47. A review on thermal analyses of cyclodextrins and cyclodextrin complexes10.1007/s10311-018-0806-8 ↗
48. The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin10.1016/j.jpba.2015.09.033 ↗
49. Guidance to improve the scientific value of zeta-potential measurements in nanoEHS10.1039/C6EN00136J ↗
50. DLS and zeta potential - what they are and what they are not?10.1016/j.jconrel.2016.06.017 ↗
51. Core–shell superparamagnetic Fe3O4@β-CD composites for host–guest adsorption of polychlorinated biphenyls (PCBs)10.1016/j.jcis.2015.01.061 ↗
52. Enhanced MRI T 2 relaxivity in contrast-probed anchor-free PEGylated iron oxide nanoparticles10.1186/s11671-017-2084-y ↗
53. Introduction to nanofluid
54. β-Cyclodextrin and its derivatives functionalized magnetic nanoparticles for targeting delivery of curcumin and cell imaging10.1002/cjoc.201500756 ↗
55. Fe3O4-PAA–(HP-γ-CDs) biocompatible ferrimagnetic nanoparticles for increasing the efficacy in superparamagnetic hyperthermia10.3390/nano12152577 ↗
56. Cyclodextrin-based magnetic nanoparticles for cancer therapy10.3390/nano8030170 ↗
57. Stimuli responsive nano-composite co-delivery of Doxorubicin and ciprofloxacin using HPLC-UV combined spectroscopy methods
58. Analysis of spectroscopic, optical and magnetic behaviour of PVDF/PMMA blend embedded by magnetite (Fe3O4) nanoparticles10.4236/opj.2020.108021 ↗
59. Optical and morphology properties of the magnetite (Fe3O4) nanoparticles prepared by green method10.1088/1742-6596/1829/1/012022 ↗
60. Influence of different capping agents on the structural, optical, and photocatalytic degradation efficiency of magnetite (Fe3O4) nanoparticles10.3390/nano13142067 ↗
61. Role of citric acid/glycine-reinforced nanometal oxide for the enhancement of physio-chemical specifications in catalytic properties10.1007/s10948-020-05607-x ↗
62. Effective adsorptive performance of Fe3O4@SiO2 core shell spheres for methylene blue: kinetics, isotherm and mechanism10.1007/s10934-019-00744-8 ↗
63. Synthesis and some physical properties of magnetite (Fe3O4) nanoparticles10.1016/S1452-3981(23)19655-6 ↗
64. Structure–property–function relationships of iron oxide multicore nanoflowers in magnetic hyperthermia and photothermia10.1021/acsnano.1c06212 ↗
65. Insights into the magnetic properties of sub-10 nm iron oxide nanocrystals through the use of a continuous growth synthesis10.1021/acs.chemmater.8b02389 ↗
66. Monodisperse sodium oleate coated magnetite high susceptibility nanoparticles for hyperthermia applications10.1016/j.jmmm.2014.04.001 ↗
67. Influence of different synthesis conditions on properties of oleic acid-coated-Fe3O4 nanoparticles10.1515/msp-2015-0027 ↗
68. Parametric Rietveld refinement and magnetic characterization of superparamagnetic iron oxide nanoparticles10.1016/j.jmmm.2018.02.020 ↗
69. Thiolated β-cyclodextrin modified iron oxide nanoparticles for effective targeted cancer therapy
70. Magnetic hyperthermia investigation of cobalt ferrite nanoparticles: comparison between experiment, linear response theory, and dynamic hysteresis simulations10.1063/1.4729271 ↗
71. Heat generation in magnetic hyperthermia by manganese ferrite-based nanoparticles arises from néel collective magnetic relaxation10.1021/acsanm.2c01536 ↗
72. Iron oxide mediated photothermal therapy in the second biological window: a comparative study between magnetite/maghemite nanospheres and nanoflowers10.3390/nano10081548 ↗
73. Magnetic nanoparticles for in vivo use: a critical assessment of their composition10.1021/jp5055765 ↗
74. Sol–gel synthesis of 8 nm magnetite (Fe3O4) nanoparticles and their magnetic properties10.1016/j.spmi.2012.07.009 ↗
75. Magnetic properties of magnetite nanoparticles synthesized by forced hydrolysis10.1016/j.matlet.2008.06.053 ↗
76. Quantitative determination of magnetite and maghemite in iron oxide nanoparticles using Mössbauer spectroscopy10.1007/s42452-019-1699-2 ↗
77. Progress in magnetic Fe3O4 nanomaterials in magnetic resonance imaging10.1515/ntrev-2020-0095 ↗
78. Fe3O4 nanoparticles modified by CD-containing star polymer for MRI and drug delivery10.1016/j.colsurfb.2017.06.049 ↗
79. Citrate modified β-cyclodextrin functionalized magnetite nanoparticles: a biocompatible platform for hydrophobic drug delivery10.1039/C4RA16044D ↗
80. HP-β-CD functionalized Fe3O4/CNPs-based theranostic nanoplatform for pH/NIR responsive drug release and MR/NIRFL imaging-guided synergetic chemo/photothermal therapy of tumor10.1021/acsami.8b09999 ↗
81. Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold-iron oxide nanocomposites: a pH-sensitive targeted drug delivery system for brain cancer theranostics10.1016/j.ejps.2017.12.008 ↗
82. Folic acid decorated magnetic nanosponge: an efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging10.1016/j.jcis.2019.08.046 ↗
83. Folic acid-decorated β-cyclodextrin-based poly(ε-caprolactone)-dextran star polymer with disulfide bond-linker as theranostic nanoparticle for tumor-targeted mri and chemotherapy10.3390/pharmaceutics14010052 ↗
84. Iron oxide nanoparticle encapsulated; folic acid tethered dual metal organic framework-based nanocomposite for MRI and selective targeting of folate receptor expressing breast cancer cells10.1016/j.micromeso.2022.112008 ↗
85. Near-infrared fluorophores for biomedical imaging10.1038/s41551-016-0010 ↗
86. Photoacoustic microscopy10.1002/lpor.201200060 ↗
87. Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics10.1364/BOE.3.002500 ↗
88. Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer10.1089/0892779041271715 ↗
89. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique10.1080/02656730500158360 ↗
90. Magnetic nanoparticles for interstitial thermotherapy - feasibility, tolerance and achieved temperatures10.1080/02656730601106037 ↗
91. Magnetic nanoparticle heating and heat transfer on a microscale: Basic principles, realities and physical limitations of hyperthermia for tumour therapy10.3109/02656736.2013.822993 ↗
92. Assessing magnetic and inductive thermal properties of various surfactants functionalised Fe3O4 nanoparticles for hyperthermia10.1038/s41598-020-71703-6 ↗
93. Synthesis and characterization of monodispersed water dispersible Fe3O4 nanoparticles and in vitro studies on human breast carcinoma cell line under hyperthermia condition10.1038/s41598-018-32934-w ↗
94. Esterification influence in thermosensitive behavior of copolymers PNIPAm-co-PAA and PNVCL-co-PAA in magnetic nanoparticles surface10.1016/j.colsurfa.2019.04.011 ↗
95. Fe3O4–SiO2 mesoporous core/shell nanoparticles for magnetic field-induced ibuprofen-controlled release10.1021/acs.langmuir.2c02408 ↗
96. Micellar assisted aqueous stabilization of iron oxide nanoparticles for curcumin encapsulation and hyperthermia application10.1016/j.nanoso.2020.100466 ↗
97. Temperature controlled camptothecin release from biodegradable magnetic PLGA microspheres10.1016/j.jmmm.2018.09.011 ↗
98. Fabrication of magnetic core/shell hydrogels via microfluidics for controlled drug delivery10.1016/j.ces.2021.117216 ↗
99. Fe3O4-PAA–(HP-γ-CDs) biocompatible ferrimagnetic nanoparticles for increasing the efficacy in superparamagnetic hyperthermia10.3390/nano12152577 ↗
100. Evaluation of solubility, dissolution rate, and oral bioavailability of β-cyclodextrin and hydroxypropyl β-cyclodextrin as inclusion complexes of the tyrosine kinase inhibitor, alectinib10.3390/ph17060737 ↗